<table border="0" cellpadding="5" width="550" cellspacing="5" height="400" >
<tr valign="top" height="400" >
<td tEditID="c1r1" style=" background-color:#FFFFFF; bEditID:r3st1; color:#000000; bLabel:main; font-size:12pt; font-family:arial;" aEditID="c1r1" locked="0" >
<![CDATA[<p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">Dear Dr. {!Contact.LastName},</span></p>
<p class="p2" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1"></span><br></p>
<p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">As promised I am following up with our posters, presentation and press as well as specific next steps from our meeting.&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">Please follow this&nbsp;<a href="https://guardanthealth.box.com/s/mzhb1oyairqtju8n3j8illx0ffyvsjco"><span class="s2">Box link</span></a>&nbsp;to access the posters we can share (some being held back for publication purposes) along with the presentation Phil Mack of UC Davis gave on the results from our first 15,000 patients.&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">We were thrilled this data was selected for one of the late breaking abstracts and you can access the press release&nbsp;<a href="http://www.asco.org/about-asco/press-center/news-releases/liquid-biopsy-may-help-guide-treatment-decisions-advanced"><span class="s2">here</span></a>, as well subsequent stories in the&nbsp;<a href="http://www.nytimes.com/2016/06/05/health/liquid-cancer-test-offers-hope-for-alternative-to-painful-biopsies.html?_r=1"><span class="s2">New York Times</span></a>,&nbsp;<a href="https://www.washingtonpost.com/news/to-your-health/wp/2016/06/04/liquid-biopsy-study-offers-hope-for-blood-test-for-finding-cancer/"><span class="s2">Washington Post</span></a>,&nbsp;<a href="http://www.economist.com/news/science-and-technology/21700125-it-will-also-pave-way-cures-personalisation-cancer-treatments"><span class="s2">Economist</span></a>,&nbsp;<a href="http://fortune.com/2016/06/05/asco-guardant-liquid-biopsy/?utm_source=twitterfeed&amp;utm_medium=twitter"><span class="s2">Fortune</span></a>,&nbsp;<a href="http://www.businessinsider.com/how-liquid-biopsies-could-help-treat-cancer-2016-6"><span class="s2">Business Insider</span></a>&nbsp;and&nbsp;<a href="http://time.com/4357037/blood-test-cancer/"><span class="s2">Time</span></a>, among others.</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">Our partners at Samsung Medical Center presented data from the first prospective clinical utility trial of 200 patients using results from Guardant360 testing and achieved 88% response rate in lung and 60% response rate in gastric. Press release&nbsp;<a href="http://www.prnewswire.com/news-releases/first-prospective-clinical-utility-trial-using-comprehensive-liquid-biopsy-to-guide-metastatic-cancer-patients-to-molecularly-matched-therapies-demonstrates-comparable-results-to-tissue-based-testing-300279906.html"><span class="s2">here</span></a>&nbsp;and Fierce Medical Devices story&nbsp;<a href="http://www.fiercemedicaldevices.com/story/guardant-liquid-biopsy-matches-cancer-patients-treatment-comparable-tumor-b/2016-06-06"><span class="s2">here</span></a>.</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">Furthermore, lots of people have been asking about our early detection project, LUNAR. Here&nbsp;is a link to the&nbsp;<a href="http://www.prnewswire.com/news-releases/guardant-health-announces-project-lunar-an-ambitious-multi-arm-multi-site-umbrella-trial-to-study-blood-test-for-early-cancer-detection-300275283.html"><span class="s3">press release</span></a>&nbsp;and Guardant&nbsp;<a href="http://guardanthealth.com/lunar/"><span class="s3">landing page</span></a>.</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">&nbsp;</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;">

















</p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">Best,</span></p>
<p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1">{!Contact.OwnerFullName}</span></p><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1"><br></span></p><p class="p1"><font face="arial" size="1">This e-mail, including any attachments may contain material protected and governed by the Health Insurance and Portability and Accountability Act (HIPAA). This e-mail and any files transmitted with it are confidential and are intended solely for the use of the individual or entity to which they are addressed. The authorized recipient of this information is prohibited from disclosing this information to any other party unless authorized. If you are not the intended recipient of this e-mail please note that you have received this e-mail in error and any use, dissemination, forwarding, printing or copying of this e-mail is strictly prohibited. If you have received this e-mail in error, please immediately contact the sender of this message.</font></p><div style="color: rgb(0, 0, 0); font-family: arial;"><br></div><div class="pbBody" style="color: rgb(0, 0, 0); font-family: Arial, Helvetica, sans-serif; margin: 7px 12px; padding: 0px; background-image: none;"><div id="thePage:theForm:thePageBlock:j_id2"></div></div><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1"></span></p><div class="pbBottomButtons" style="color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif; font-size: 12px; margin: 20px 0px 0px; background-image: none; border-top: 1px solid rgb(219, 219, 219);"><table border="0" cellpadding="0" cellspacing="0" style="border-spacing: 0px; width: 948px; border-top: 1px solid rgb(255, 255, 255);"><tbody><tr></tr></tbody></table></div><p class="p1" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1"><br></span></p>
<p class="p8" style="color: rgb(0, 0, 0); font-family: arial; font-size: 12pt;"><span class="s1"></span><br></p>]]></td>
</tr>
</table>